Nektar Therapeutics · NASDAQ:NKTR

BVF PARTNERS L P/IL reported a 7.10% stake in Nektar Therapeutics (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

BVF PARTNERS L P/IL reported a 7.10% stake in Nektar Therapeutics, 2,391,075 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
7.10%
Shares
2,391,075
Intent
Passive
What changed
Stake changed
Filed together
10 holders

The filing in full

HolderStakeShares
BIOTECHNOLOGY VALUE FUND L P3.70%1,251,654
BVF I GP LLC3.70%1,251,654
BIOTECHNOLOGY VALUE FUND II LP2.80%945,732
BVF II GP LLC2.80%945,732
Biotechnology Value Trading Fund OS LP0.50%157,488
BVF Partners OS Ltd.0.50%157,488
BVF GP HOLDINGS LLC6.50%2,197,386
BVF PARTNERS L P/IL7.10%2,391,075
BVF INC/IL7.10%2,391,075
LAMPERT MARK N7.10%2,391,075

Source

View original at SEC

Related